IRB Barcelona opens new laboratory focused on targeted protein degradation as a therapeutic tool Blog Post

Scientist Cristina Mayor-Ruiz joins the Institute for Research in Biomedicine (IRB Barcelona) to lead the new Targeted Protein Degradation and Drug Discovery Lab. Along with the addition of this group, the Institute, based in the Barcelona Science Park, is also launching a Drug Screening Unit, thereby reflecting a clear commitment to speeding up the transfer of basic research to clinical practice.


Great success of the 13th IBEC Symposium “Bioengineering for Future & Precision Medicine” Blog Post

The Institute for Bioengineering of Catalonia (IBEC), based in the Barcelona Science Park, organized from the 27th to the 28th October its 13th Symposium. The event, that this year took place for the first time online, was focused on “Bioengineering for Future & Precision Medicine”. With more than 400 registered attendees, the event also counted with contributions from top international speakers.


Researchers reveal the evolutionary events leading to the creation of eukaryotic cells Blog Post

A collaborative study between the groups of Toni Gabaldón, ICREA researcher at the Institute for Research in Biomedicine (IRB Barcelona) and Berend Snel at the University of Utrecht, has reconstructed the evolutionary events leading to the creation of eukaryotic cells, the precursors to virtually all life you can see with the naked eye. The work, published in Nature Ecology & Evolution, reveals that The evolutionary timeline from simple bacterial cells to complex eukaryotic cells progressed differently than previously thought.


SOM Biotech identifies eravacycline as an effective treatment against SARS-CoV-2 Blog Post

The biopharmaceutical company SOM Biotech,based in the Barcelona Science Park, announces the preclinical validation studies of eravacycline as an effective treatment against SARS-CoV-2. The conclusions of the studies will be presented at the virtual event IDWeek 2020. that will be held from October 21 to 25. Eravacycline is one of the three drugs that the company has identified and validated in collaboration with Ewha Womans University for the treatment of the new coronavirus, and SOM already plans to carry out a Phase 2 clinical trial.



The Barcelona Science Park is committed to becoming Catalonia’s MedTech company hub Blog Post

The Barcelona Science Park (PCB), a Spain’s leading scientific, technological and business innovation hub in the life sciences field, aims to embark on a new phase of growth, offering more than 1,200 square metres of office space, particularly to companies in the MedTech sector. To promote this ecosystem, it has signed an alliance with GENESIS Biomed. This consultancy firm, based in PCB, has raised more than 60 million euros for its clients since it was founded in May 2017 by Josep Lluis Falcó.


Kumux launches a 2.0 software which creates differential light to improve human health and plant growth Blog Post

A spin-off by the University of Barcelona Enlighting Technologies, based in the Barcelona Science Park, has created Kumux to launch a 2.0 simulation spectrum software which, through patented algorithms, creates a differential light with beneficial effects for health for both people and plant growth. It is an smart lighting solution –autonomous and based on LED technology–, compatible with different systems and designed so that it can be integrated into any luminaire or control platform.


Judit Cubedo, CEO of GlyCardial, finalist for the EU Prize for Women Innovators 2020 Blog Post

Judit Cubedo, co-founder and CEO of GlyCardial Diagnostics, is one of the twenty-one women selected as finalists for the EU Prize for Women Innovators 2020, an award given annually to the most talented and inspiring entrepreneurs in Europe. The company led by Judit, which is based in the Barcelona Science Park, is conducting a clinical trial to validate the performance of Apo J-Glyc as a novel biomarker for the early detection of Myocardial Ischaemia. The award winners will be announced at the European Research and Innovation Days taking place on 22-24 September 2020.


A global team involving ICUB-Tech researchers detects a type of unidentified astronomical object Blog Post

Researchers from the international collaborations LIGO and Virgo, in which the Institute of Cosmos Sciences of the UB (ICCUB) takes part under the coordination of Jordi Portell –co-director of the ICCUB Technology Unit, based in the Barcelona Science Park– have announced the discovery of an object of 2.6 solar masses, placing it firmly into so-called mass gap. That is an interval between the mass of the heaviest neutron star and the lightest blackhole, from which there were no observations yet.


Eugin presents pioneering advances in fertility and human reproduction at ESHRE 2020 Blog Post

An analysis of the environment in which the embryos that become implanted in the uterus develop reveals a lower number of senescent (aged) cells than those that are not successful. This is the result of a study presented yesterday at ESHRE 2020, which has been led by researchers from Eugin’s Basic Research Laboratory, headquartered in the Barcelona Science Park. The group also submited at the congress another work –carried out with the Center for Genomic Regulation (CRG) and the collaboration of the National Center for Genomic Analysis (CNAG)– which reveals that the quality of the eggs can lie in the networks that create their genes.